On Jun 5, British drugmaker AstraZeneca started manufacturing the University of Oxfordâ€™s potential coronavirus vaccine ahead of trial results and has doubled its capacity to two billion doses.German pharmaceutical giant Pfizer, Inc. PFE, which is working in collaboration with BioNTech SE BNTX, recently said that a coronavirus vaccine could be ready for emergency use as early as September.